CA2080493A1 - Peptides de synthese pour la visualisation arterielle - Google Patents

Peptides de synthese pour la visualisation arterielle

Info

Publication number
CA2080493A1
CA2080493A1 CA002080493A CA2080493A CA2080493A1 CA 2080493 A1 CA2080493 A1 CA 2080493A1 CA 002080493 A CA002080493 A CA 002080493A CA 2080493 A CA2080493 A CA 2080493A CA 2080493 A1 CA2080493 A1 CA 2080493A1
Authority
CA
Canada
Prior art keywords
peptide
analog
peptide analog
vascular
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002080493A
Other languages
English (en)
Inventor
Robert S. Lees
Ann M. Lees
Allan Fischman
Ing-Lung Shih
Mark A. Findeis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beth Israel Deaconess Medical Center Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2080493A1 publication Critical patent/CA2080493A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
CA002080493A 1990-05-03 1991-05-02 Peptides de synthese pour la visualisation arterielle Abandoned CA2080493A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51814290A 1990-05-03 1990-05-03
US51821590A 1990-05-03 1990-05-03
US518,142 1990-05-03
US518,215 1990-05-03

Publications (1)

Publication Number Publication Date
CA2080493A1 true CA2080493A1 (fr) 1991-11-04

Family

ID=27059361

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002080493A Abandoned CA2080493A1 (fr) 1990-05-03 1991-05-02 Peptides de synthese pour la visualisation arterielle

Country Status (5)

Country Link
EP (1) EP0600869A1 (fr)
JP (1) JPH05507276A (fr)
AU (1) AU663291B2 (fr)
CA (1) CA2080493A1 (fr)
WO (1) WO1991016919A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726153A (en) * 1988-05-02 1998-03-10 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US5972890A (en) * 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5997844A (en) * 1991-02-08 1999-12-07 Diatide, Inc. Technetium-99m labeled peptides for imaging
WO1993017719A1 (fr) * 1992-03-13 1993-09-16 Diatech, Inc. PEPTIDES MARQUES AU TECHNETIUM-99m POUR LA MISE EN IMAGE D'UNE INFLAMMATION
US5989519A (en) * 1992-03-13 1999-11-23 Diatide, Inc. Technetium-99m labeled peptides for imaging inflammation
WO1994004563A1 (fr) * 1992-08-14 1994-03-03 Shino-Test Corporation PEPTIDES CONTENANT DES SEQUENCES D'ACIDES AMINES RESPECTIVES SELECTIONNEES PARMI CELLES DE LA LIPOPROTEINE(a) ET DE L'APOLIPOPROTEINE(a), ANTICORPS RECONNAISSANT CES SEQUENCES D'ACIDES AMINES ET PROCEDE D'ANALYSE UTILISANT CES ANTICORPS
US5605671A (en) * 1992-10-05 1997-02-25 The Regents Of The University Of Michigan Radiolabeled neutrophil activating peptides for imaging
US5413778A (en) * 1992-10-05 1995-05-09 The Regents Of The University Of Michigan Labelled monocyte chemoattractant protein material and medical uses thereof
AU5537994A (en) * 1992-10-22 1994-05-09 Mallinckrodt Medical, Inc. Therapeutic treatment for inhibiting vascular restenosis
DE4301871A1 (de) * 1993-01-13 1994-07-14 Diagnostikforschung Inst Neue Mittel zur Diagnose von Gefäßerkrankungen
DE4425778A1 (de) * 1994-07-13 1996-01-18 Diagnostikforschung Inst Komplexverbindungen zur Diagnose von Gefäßerkrankungen
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
WO1998005685A2 (fr) * 1996-08-07 1998-02-12 Protein Specialties, Ltd. Peptides s'alignant automatiquement et derives de l'elastine et d'autres proteines fibreuses
US6605588B1 (en) 1996-11-27 2003-08-12 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6632923B1 (en) 1996-11-27 2003-10-14 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6355451B1 (en) 1996-11-27 2002-03-12 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US7368099B2 (en) * 2003-02-27 2008-05-06 Kyushu University, National University Corporation MRI contrast agents
AU2008251900A1 (en) 2007-05-10 2008-11-20 Elastin Specialties, Inc. Synthetic peptide materials for joint reconstruction, repair and cushioning
GB201102189D0 (en) * 2011-02-08 2011-03-23 King S College London Materials and methods relating to cardiovascular imaging
WO2023086771A2 (fr) * 2021-11-05 2023-05-19 Trustees Of Tufts College Matériaux pour la récupération de métaux de valeur

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1242643A (fr) * 1983-08-12 1988-10-04 Eric T. Fossel Imagerie medicale par rmn faisant appel a des reactifs provoquant des deplacements chimiques
US4643988A (en) * 1984-05-15 1987-02-17 Research Corporation Amphipathic peptides
US4660563A (en) * 1984-12-31 1987-04-28 Massachusetts Institute Of Technology Method and means for detection of arterial lesions
JPS62501770A (ja) * 1984-12-31 1987-07-16 ゾマ、コーポレーション ヒトアポリポタンパク質のペプチドフラグメント、種特異性抗体及び使用方法
US4976734A (en) * 1985-10-31 1990-12-11 Uab Research Foundation Stimulation of chemotaxis by chemotactic peptides
AU628357B2 (en) * 1988-05-02 1992-09-17 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging

Also Published As

Publication number Publication date
JPH05507276A (ja) 1993-10-21
AU7992891A (en) 1991-11-27
EP0600869A1 (fr) 1994-06-15
WO1991016919A1 (fr) 1991-11-14
EP0600869A4 (fr) 1993-03-22
AU663291B2 (en) 1995-10-05

Similar Documents

Publication Publication Date Title
US5955055A (en) Synthetic peptides for arterial imaging at vascular imaging sites
AU663291B2 (en) Synthetic peptides for arterial imaging
US5759515A (en) Polyvalent peptide pharmaceutical applications
Virgolini et al. Experience with indium-111 and yttrium-90-labeled somatostatin analogs
AU2001292456B2 (en) Peptide-based compounds
KR100341014B1 (ko) 진단영상용의테크네튬-99m표지된펩티드
WO1998052618A1 (fr) Agents radiomarques permettant de produire des images d'un thrombus
EP0733060B1 (fr) Chelateurs de metaux
JP2003531835A (ja) ペプチドベースの化合物
AU2001292456A1 (en) Peptide-based compounds
US5726153A (en) Synthetic peptides for arterial imaging
CN102014970A (zh) 99mTc标记的含19个氨基酸的多肽作为磷脂酰乙醇胺结合分子探针和放射性药物的用途
JPH08502480A (ja) 放射能標識されたディスインテグリンを使用する血栓検出
AU628357B2 (en) Synthetic peptides for arterial imaging
AU666059B2 (en) New agents for diagnosis of vascular diseases
van der Laken et al. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction
JPH09512555A (ja) テクネチウム−９９ｍ標識イメージング剤
JP2710645B2 (ja) ｓｎＲＮＰ−Ａ抗原及びそのフラグメント
Uehara et al. Iodine-131-labeled fibronectin: potential agent for imaging atherosclerotic lesion and thrombus
US7575738B2 (en) Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
CA2348617A1 (fr) Production d'images avec un peptide a chaine .alpha. fibrine marque au tc-99m
JP2022088462A (ja) 炎症のイメージングのための分子標識としてのＣＤ３１ｓｈｅｄ
Möllmann Design of Molecular Ligands for (Nuclear) Imaging

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead